Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes

Frank DiPaola1, Andrew T Trout2,3, Ashley E Walther4

  • 1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, C.S. Mott Children's Hospital, MPB D5200, 1500 East Medical Center Drive, SPC 5718, Ann Arbor, MI, 48109-5718, USA. dipaolaf@med.umich.edu.

Insights

Congenital portosystemic shunt (CPSS) is a rare condition linked to other anomalies. Early diagnosis and management of CPSS, including liver lesions, are crucial for preventing serious complications in children and young adults.

Area of Science:

  • Pediatric Surgery
  • Hepatology
  • Medical Malformations

Background:

  • Congenital portosystemic shunt (CPSS) is a rare vascular malformation bypassing the liver.
  • It is frequently associated with other congenital anomalies and syndromes.
  • CPSS and its management are underreported, necessitating further clinical review.

Purpose of the Study:

  • To review clinical characteristics, management strategies, and outcomes of CPSS in pediatric patients.
  • To define CPSS anatomy, associated anomalies, and complications.
  • To characterize liver lesions and their management in CPSS patients.

Main Methods:

  • Retrospective review of 11 CPSS cases from two pediatric centers.
  • Detailed characterization of CPSS anatomy, associated anomalies, and clinical presentations.
  • Analysis of imaging features and histopathology of liver lesions, interventions, and outcomes.

Main Results:

  • The cohort (median age 10 years) showed high prevalence of heterotaxy, congenital heart disease, and Turner syndrome.
  • Hyperammonemia/encephalopathy occurred in 73% of cases; hepatopulmonary syndrome and pulmonary hypertension were also observed.
  • Eight patients had liver lesions, including premalignant adenomas and hepatocellular carcinoma (HCC), managed with occlusion, ligation, or liver transplantation.

Conclusions:

  • CPSS is associated with significant anomalies and syndromes, requiring careful evaluation.
  • Liver lesions in CPSS patients carry a risk of premalignant adenomas and HCC.
  • Timely management, including endovascular or surgical interventions, can address serious CPSS complications.
Abstract

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
378
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
496
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.2K